Whitepaper

Whats Now and Next in Immuno-Oncology?

Market Research

Immuno- Oncology is a unique therapy in the precision medicine space that is showing extraordinary promise in combating Cancer. These next-generation therapeutic drugs differ from conventional methods as they stimulate the immune system to selectively attack cancer cells while ensuring healthy cells remain unaffected. Cancer cells adapt to express proteins that let them hide from the normal anti-tumor immune response.

The objective of Immuno-Oncology is to interrupt this process of spreading cancer cells and revitalize the immune system to detect and destroy malignancies. Such therapies have shown great promise in several clinical trials, contributing to the widespread adoption across the pharmaceuticals and life sciences industry.

This report describes in more detail how the Immuno-Oncology market evolved and the current market scenario. It also answers the following questions:

  • What key drivers are leading to the successful development of therapies?
  • Who are key industry players and what are their initiatives?
  • How can pharmaceutical companies leverage innovative technology to counter major challenges?

To know more...




Authors

Related Topics

ATxSG Broadcast Asia 2024

Whitepapers

ATxSG BroadcastAsia 2024: Key Trends

ATxSG is one of the leading technology conferences in Asia-Pacific with two primary focus avenues, i.e., BroadcastAsia and CommunicAsia, with close to...

NAB 2024 Key Trends

Whitepapers

NAB 2024 Key Trends

SG Analytics (SGA)’s media and broadcast research & consulting team surveyed 13 vendors attending the 2024 NAB Show in Las Vegas in April 2024....

Whitepaper - ESG-M&E - Sustainable Media

Whitepapers

A Shift toward Sustainable Media Consumption Imminent

Short description & Key Takeaways for the website: There are roughly 500+ OTT TV & video services globally with 6.3bn users worldwide generating...

We bring comprehensive data driven insights to everyone, everywhere